SNGX Soligenix, Inc.
$0.36▲ +1.08%
Healthcare
Other
After hours
$0.38▲ +3.13%
Sep 11, 7:50 PM ET
Volume 147.2K
Avg Volume (10D) 161.7K
Key Metrics & Fundamentals
Market Cap
$7.92M
P/E Ratio
–
Div Yield
–%
52W Range
0.28 - 2.98
% vs 50 MA
-3.37%
% vs 200 MA
-58.28%
RSI-14
40.5
MACD Histogram
+0.0000
Beta (1Y vs SPY)
2.08
Free Cash Flow
-$2.36M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$2.88M
COGS
$0
Operating Exp
$2.88M
Operating Income
-$2.88M
EBIT
-$2.88M
Pretax Income
-$2.82M
Net Income
-$2.82M
EPS (Diluted)
-0.28
Price & Volume History
Loading chart…
Recent News
Radiotherapy-Induced Oral Mucositis Market Set for Strong Growth Through 2036, Driven by Emerging Therapies and Rising Cancer Burden | DelveInsight
PR Newswire · Aug 20, 2026 2:31 PM
SNGX: Applying for Vaccine Development Funding for Ebola Vaccine
Zacks Small Cap Research · Aug 12, 2026 11:25 AM
Soligenix culls topical lymphoma asset after Phase III miss
Clinical Trials Arena · Aug 10, 2026 11:09 AM
Soligenix Announces Recent Updates and Second Quarter 2026 Financial Results
PR Newswire · Aug 7, 2026 11:30 AM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See SNGX's money flow as a full page
Social Sentiment
No Reddit posts found for SNGX.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.